The group reported a net profit of Rs 16.11 crore in the second quarter last financial year, Crisil said in a filling to the BSE. The consolidated total income rose to Rs 132.31 crore in the second quarter from Rs 96.91 crore in the year-ago period.
Despite the volatility in the equity markets, Crisil research assigned IPO grading to seven companies during the quarter, broadly in line with trends in earlier quarters, it added.
The board has recommended an interim dividend of Rs 10 per share of face value Rs 10 each.
The board of director has also approved a proposal to set up a subsidiary or branch in Dubai with an investment of up to $5,00,000 to establish a delivery centre for outsourced research business procured by Irevna. Shares of the company closed at Rs 3,695 on the BSE on Thursday.